Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
7 "Il Ju Choi"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
A Machine Learning Risk Prediction Model for Gastric Cancer with SHapley Additive exPlanations
Bomi Park, Chung Ho Kim, Jae Kwan Jun, Mina Suh, Kui Son Choi, Il Ju Choi, Hyun Jin Oh
Received August 29, 2024  Accepted December 15, 2024  Published online December 16, 2024  
DOI: https://doi.org/10.4143/crt.2024.843    [Epub ahead of print]
AbstractAbstract PDFSupplementary Material
Purpose
Gastric cancer (GC) prediction models hold potential for enhancing early detection by enabling the identification of high-risk individuals, facilitating personalized risk-based screening, and optimizing the allocation of healthcare resources.
Materials and Methods
In this study, we developed a machine learning-based GC prediction model utilizing data from the Korean National Health Insurance Service, encompassing 10,515,949 adults who had not been diagnosed with GC and underwent GC screening during 2013-2014, with a follow-up period of 5 years. The cohort was divided into training and test datasets at an 8:2 ratio, and class imbalance was mitigated through random oversampling.
Results
Among various models, logistic regression demonstrated the highest predictive performance, with an area under the receiver operating characteristic curve (AUC) of 0.708, which was consistent with the AUC obtained in external validation (0.669). Importantly, the outcomes were robust to missing data imputation and variable selection. The SHapley Additive exPlanations (SHAP) algorithm enhanced the explainability of the model, identifying advancing age, being male, Helicobacter pylori infection, current smoking, and a family history of GC as key predictors of elevated risk.
Conclusion
This predictive model could significantly contribute to the early identification of individuals at elevated risk for GC, thereby enabling the implementation of targeted preventive strategies. Furthermore, the integration of noninvasive and cost-effective predictors enhances the clinical utility of the model, supporting its potential application in routine healthcare settings.

Citations

Citations to this article as recorded by  
  • Development and validation of a prediction model for myelosuppression in lung cancer patients after platinum-based doublet chemotherapy: a multifactorial analysis approach
    Xueyan Li
    American Journal of Cancer Research.2025; 15(2): 470.     CrossRef
  • 850 View
  • 97 Download
  • 1 Crossref
Close layer
Gastrointestinal cancer
Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population
Hyojin Pyun, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
Cancer Res Treat. 2024;56(1):191-198.   Published online June 20, 2023
DOI: https://doi.org/10.4143/crt.2022.958
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
We aimed to identify the associated single nucleotide polymorphisms (SNPs) with gastric cancer (GC) risk by genome-wide association study (GWAS) and to explore the pathway enrichment of implicated genes and gene-sets with expression patterns.
Materials and Methods
The study population was comprised of 1,253 GC cases and 4,827 controls from National Cancer Center and an urban community of the Korean Genome Epidemiology Study and their genotyping was performed. SNPs were annotated, and mapped to genes to prioritize by three mapping approaches by functional mapping and annotation (FUMA). The gene-based analysis and gene-set analysis were conducted with full GWAS summary data using MAGMA. Gene-set pathway enrichment test with those prioritized genes were performed.
Results
In GWAS, rs2303771, a nonsynonymous variant of KLHDC4 gene was top SNP associated significantly with GC (odds ratio, 2.59; p=1.32×10–83). In post-GWAS, 71 genes were prioritized. In gene-based GWAS, seven genes were under significant p < 3.80×10–6 (0.05/13,114); DEFB108B had the lowest p=5.94×10–15, followed by FAM86C1 (p=1.74×10–14), PSCA (p=1.81×10–14), and KLHDC4 (p=5.00×10–10). In gene prioritizing, KLDHC4 was the only gene mapped with all three gene-mapping approaches. In pathway enrichment test with prioritized genes, FOLR2, PSCA, LY6K, LYPD2, and LY6E showed strong enrichment related to cellular component of membrane; a post-translation modification by synthesis of glycosylphosphatidylinositol (GPI)-anchored proteins pathway.
Conclusion
While 37 SNPs were significantly associated with the risk of GC, genes involved in signaling pathways related to purine metabolism and GPI-anchored protein in cell membrane are pinpointed to be playing important role in GC.

Citations

Citations to this article as recorded by  
  • A rare KLHDC4 variant Glu510Lys is associated with genetic susceptibility and promotes tumor metastasis in nasopharyngeal carcinoma
    Xi-Xi Cheng, Guo-Wang Lin, Ya-Qing Zhou, Yi-Qi Li, Shuai He, Yang Liu, Yan-Ni Zeng, Yun-Miao Guo, Shu-Qiang Liu, Wan Peng, Pan-Pan Wei, Chun-Ling Luo, Jin-Xin Bei
    Journal of Genetics and Genomics.2025; 52(4): 559.     CrossRef
  • Investigating the Shared Genetic Architecture Between Leukocyte Telomere Length and Prostate Cancer
    Zhizhou Li, Maoyu Wang, Shuxiong Zeng, Ziwei Wang, Yidie Ying, Qing Chen, Chen Zhang, Wei He, Chaoyang Sheng, Yi Wang, Zhensheng Zhang, Chuanliang Xu, Huiqing Wang
    The World Journal of Men's Health.2024;[Epub]     CrossRef
  • 4,561 View
  • 222 Download
  • 3 Web of Science
  • 2 Crossref
Close layer
Genome-Wide Association of Genetic Variation in the PSCA Gene with Gastric Cancer Susceptibility in a Korean Population
Boyoung Park, Sarah Yang, Jeonghee Lee, Hae Dong Woo, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Young-Il Kim, Jeongseon Kim
Cancer Res Treat. 2019;51(2):748-757.   Published online September 5, 2018
DOI: https://doi.org/10.4143/crt.2018.162
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Half of the world’s gastric cancer cases and the highest gastric cancer mortality rates are observed in Eastern Asia. Although several genome-wide association studies (GWASs) have revealed susceptibility genes associated with gastric cancer, no GWASs have been conducted in the Korean population, which has the highest incidence of gastric cancer.
Materials and Methods
We performed genome scanning of 450 gastric cancer cases and 1,134 controls via Affymetrix Axiom Exome 319 arrays, followed by replication of 803 gastric cancer cases and 3,693 healthy controls.
Results
We showed that the rs2976394 in the prostate stem cell antigen (PSCA) gene is a gastriccancer-susceptibility gene in a Korean population, with genome-wide significance and an odds ratio (OR) of 0.70 (95% confidence interval [CI], 0.64 to 0.77). A strong linkage disequilibrium with rs2294008 was also found, indicating an association with susceptibility. Individuals with the CC genotype of the PSCA gene showed an approximately 2-fold lower risk of gastric cancer compared to those with the TT genotype (OR, 0.47; 95% CI, 0.39 to 0.57). The effect of the PSCA gene on gastric cancer was more prominent in the female population and for diffuse type gastric cancer.
Conclusion
Our result confirmed that the PSCA gene may be the most important susceptibility gene for gastric cancer risk in a Korean population.

Citations

Citations to this article as recorded by  
  • Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population
    Hyojin Pyun, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
    Cancer Research and Treatment.2024; 56(1): 191.     CrossRef
  • HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer
    Ansley Gnanapragasam, Eftyhios Kirbizakis, Anna Li, Kyle H. White, Katelyn L. Mortenson, Juliana Cavalcante de Moura, Wajih Jawhar, Yifei Yan, Reilly Falter, Colleen Russett, Betty Giannias, Sophie Camilleri-Broët, Nicholas Bertos, Jonathan Cools-Lartigue
    Cancer Research.2024; 84(14): 2377.     CrossRef
  • High Polygenic Risk Scores Positively Associated with Gastric Cancer Risk Interact with Coffee and Polyphenol Intake and Smoking Status in Korean Adults
    Meiling Liu, Sang-Shin Song, Sunmin Park
    Nutrients.2024; 16(19): 3263.     CrossRef
  • Dietary mercury intake, the IL23R rs10889677 polymorphism, and the risk of gastric cancer in a Korean population: a hospital-based case-control study
    Ji Hyun Kim, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Epidemiology and Health.2024; 46: e2024051.     CrossRef
  • SNP-SNP Interactions and Gastric Cancer Susceptibility in Ardabil Province
    Homa Akhavan Aghghaleh, Najmeh Ranji, Hadi Habibollahi
    Journal of Ardabil University of Medical Sciences.2024; 24(3): 364.     CrossRef
  • Interaction between dietary potassium intake and TNF-α rs1800629 genetic polymorphism in gastric cancer risk: a case–control study conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    British Journal of Nutrition.2023; 130(5): 887.     CrossRef
  • Rare variants confer shared susceptibility to gastrointestinal tract cancer risk
    Ji Zheng, Xin Wang, Jingrao Li, Yuanna Wu, Jiang Chang, Junyi Xin, Meilin Wang, Tianpei Wang, Qingyi Wei, Mengyun Wang, Ruoxin Zhang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The association of dietary fibre intake and the IL13 rs20541 polymorphism with the risk of gastric cancer: a case-control study in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Clinical Nutrition.2022; 76(7): 1031.     CrossRef
  • Systematic review of gastric cancer-associated genetic variants, gene-based meta-analysis, and gene-level functional analysis to identify candidate genes for drug development
    Sangjun Lee, Han-Kwang Yang, Hyuk-Joon Lee, Do Joong Park, Seong-Ho Kong, Sue K. Park
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Incidence of Hereditary Gastric Cancer May Be Much Higher than Reported
    Paula Baraúna de Assumpção, Paulo Pimentel de Assumpção, Fabiano Cordeiro Moreira, Ândrea Ribeiro-dos-Santos, Amanda F. Vidal, Leandro Magalhães, André Salim Khayat, André Maurício Ribeiro-dos-Santos, Giovanna C. Cavalcante, Adenilson Leão Pereira, Inácio
    Cancers.2022; 14(24): 6125.     CrossRef
  • Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility
    Rachel Martini, Endale Gebregzabher, Lisa Newman, Melissa B. Davis
    Cancer Discovery.2022; 12(6): 1428.     CrossRef
  • Identification of Novel Susceptible Genes of Gastric Cancer Based on Integrated Omics Data
    Huang Yaoxing, Yu Danchun, Sun Xiaojuan, Jiang Shuman, Yan Qingqing, Jia Lin
    Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
  • The Associations of Dietary Iron Intake and the Transferrin Receptor (TFRC) rs9846149 Polymorphism with the Risk of Gastric Cancer: A Case–Control Study Conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Nutrients.2021; 13(8): 2600.     CrossRef
  • Integration of GWAS and eQTL Analysis to Identify Risk Loci and Susceptibility Genes for Gastric Cancer
    Jing Ni, Bin Deng, Meng Zhu, Yuzhuo Wang, Caiwang Yan, Tianpei Wang, Yaqian Liu, Gang Li, Yanbing Ding, Guangfu Jin
    Frontiers in Genetics.2020;[Epub]     CrossRef
  • Evolutionary History of the Risk of SNPs for Diffuse-Type Gastric Cancer in the Japanese Population
    Risa L. Iwasaki, Koji Ishiya, Hideaki Kanzawa-Kiriyama, Yosuke Kawai, Jun Gojobori, Yoko Satta
    Genes.2020; 11(7): 775.     CrossRef
  • TNF genetic polymorphism (rs1799964) may modify the effect of the dietary inflammatory index on gastric cancer in a case–control study
    Jeeeun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
    Scientific Reports.2020;[Epub]     CrossRef
  • Prediction of gastric cancer risk: association between ZBTB20 genetic variance and gastric cancer risk in Chinese Han population
    Fei Bai, Ke Xiao
    Bioscience Reports.2020;[Epub]     CrossRef
  • Incidence of Stomach and Esophageal Cancers in Mongolia: Data from 2009 to 2018
    Tsegmed Sambuu, Nasanjargal Tumurbat, Bayar Davaa, Bolor-Erdene Tudev
    Euroasian Journal of Hepato-Gastroenterology.2020; 10(1): 16.     CrossRef
  • 10,628 View
  • 209 Download
  • 16 Web of Science
  • 18 Crossref
Close layer
Effects of Soy Product Intake and Interleukin Genetic Polymorphisms on Early Gastric Cancer Risk in Korea: A Case-Control Study
Sarah Yang, Yoon Park, Jeonghee Lee, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Joohon Sung, Jeongseon Kim
Cancer Res Treat. 2017;49(4):1044-1056.   Published online January 19, 2017
DOI: https://doi.org/10.4143/crt.2016.515
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The current study investigated whether the combined effects of soy intake and genetic polymorphisms of interleukin (IL) genes modify gastric cancer risk.
Materials and Methods
A total of 377 cases and 754 controls of Korean origin were included in the analysis. Soy consumption was assessed using a semi-quantitative food frequency questionnaire. Seven variants of IL10 (rs1800871), IL2 (rs2069763 and rs2069762), IL13 (rs6596090 and rs20541), and IL4R(rs7205663 and rs1805010) were genetically analyzed. To analyze the combined effect of soy intake and genetic polymorphisms, a low-intake group and high-intake group of each type of soy were categorized based on the intake level of the control group. Interactions between soy products and these genetic variants were analyzed by a likelihood ratio test, in which a multiplicative interaction term was added to the logistic regression model.
Results
A higher intake of nonfermented soy products was associated with a reduced cancer risk (odds ratio [OR], 0.62; 95% confidence interval [CI], 0.43 to 0.90), and the reduced risk was only apparent in males (OR, 0.44; 95% CI, 0.27 to 0.71). None of the IL genetic polymorphisms examined were independently associated with gastric cancer risk. Individuals with a minor allele of IL2 rs2069762 and a higher intake of nonfermented soy food had a decreased risk of gastric cancer (OR, 0.46; 95% CI, 0.31 to 0.68) compared to those with a lower intake (pinteraction=0.039).
Conclusion
Based on the genetic characteristics of the studied individuals, the interaction between IL2 rs2069762 and nonfermented soy intake may modify the risk of gastric cancer.

Citations

Citations to this article as recorded by  
  • Polyphenol intake and gastric cancer: A case-control study in the Brazilian Amazon region
    Marcela de Araújo Fagundes, Renata Alves Carnauba, Gisele Aparecida Fernandes, Paulo Pimentel de Assumpção, Maria Paula Curado
    Cancer Epidemiology.2024; 88: 102518.     CrossRef
  • Oral Microbiota as a Diagnostic Biomarker of Digestive Cancer: A Systematic Review
    SK Aziz Ikbal, Surendra Kumar Yadav, Roopanshi Mehrotra, Tasneem Fatima, Anjusha Sharda, Srashti Gupta
    The Journal of Contemporary Dental Practice.2024; 24(11): 902.     CrossRef
  • The pertinence of gastric cancer and interleukin 10–819 single nucleotide polymorphisms: a meta-analysis and systematic review
    Qianqian Mao, Yanwen Liu, Xi Chen, Cheng Jiang Liu
    BMC Gastroenterology.2024;[Epub]     CrossRef
  • Soy Product Consumption and the Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies
    Chenting Wang, Keqing Ding, Xuanzhen Xie, Jinyue Zhou, Pengju Liu, Shuang Wang, Ting Fang, Guozhang Xu, Chunlan Tang, Hang Hong
    Nutrients.2024; 16(7): 986.     CrossRef
  • Interaction between dietary potassium intake and TNF-α rs1800629 genetic polymorphism in gastric cancer risk: a case–control study conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    British Journal of Nutrition.2023; 130(5): 887.     CrossRef
  • Association between soy products, fruits, vegetables, and dairy products and gastric cancer risk in Helicobacter pylori-infected subjects: a case-control study in Korea
    Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
    Nutrition Research and Practice.2023; 17(1): 122.     CrossRef
  • Dietary intake and cancer incidence in Korean adults: a systematic review and meta-analysis of observational studies
    Ji Hyun Kim, Shinyoung Jun, Jeongseon Kim
    Epidemiology and Health.2023; 45: e2023102.     CrossRef
  • The association of dietary fibre intake and the IL13 rs20541 polymorphism with the risk of gastric cancer: a case-control study in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Clinical Nutrition.2022; 76(7): 1031.     CrossRef
  • Dietary Polyphenol Intake and Gastric Cancer: A Systematic Review and Meta-Analysis
    Marcela de Araújo Fagundes, Alex Richard Costa Silva, Gisele Aparecida Fernandes, Maria Paula Curado
    Cancers.2022; 14(23): 5878.     CrossRef
  • Sex-dependent associations between MAP3K1 gene polymorphisms and soy products with the gastric cancer risk in Korea: a case-control study
    Jung Hyun Kwak, Chang Soo Eun, Dong Soo Han, Yong Sung Kim, Kyu Sang Song, Bo Youl Choi, Hyun Ja Kim
    BMC Gastroenterology.2022;[Epub]     CrossRef
  • Dietary patterns and gastric cancer risk in a Korean population: a case–control study
    Ji Hyun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    European Journal of Nutrition.2021; 60(1): 389.     CrossRef
  • Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer
    Xujun Song, Benno Traub, Jingwei Shi, Marko Kornmann
    International Journal of Molecular Sciences.2021; 22(2): 727.     CrossRef
  • The association between soy‐based food and soy isoflavone intake and the risk of gastric cancer: a systematic review and meta‐analysis
    Yameng Wang, Jiaping Guo, Fei Yu, Yongmei Tian, Yongjun Wu, Lingling Cui, Li‐e Liu
    Journal of the Science of Food and Agriculture.2021; 101(13): 5314.     CrossRef
  • The Associations of Dietary Iron Intake and the Transferrin Receptor (TFRC) rs9846149 Polymorphism with the Risk of Gastric Cancer: A Case–Control Study Conducted in Korea
    Tao Thi Tran, Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Nutrients.2021; 13(8): 2600.     CrossRef
  • Identification of Dietary Pattern Networks Associated with Gastric Cancer Using Gaussian Graphical Models: A Case-Control Study
    Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
    Cancers.2020; 12(4): 1044.     CrossRef
  • Genome‐wide profiling of normal gastric mucosa identifies Helicobacter pylori‐ and cancer‐associated DNA methylome changes
    Hae Dong Woo, Nora Fernandez‐Jimenez, Akram Ghantous, Davide Degli Esposti, Cyrille Cuenin, Vincent Cahais, Il Ju Choi, Young‐Il Kim, Jeongseon Kim, Zdenko Herceg
    International Journal of Cancer.2018; 143(3): 597.     CrossRef
  • The association between dietary isoflavones intake and gastric cancer risk: a meta-analysis of epidemiological studies
    Jie You, Yafei Sun, Yacong Bo, Yiwei Zhu, Dandan Duan, Han Cui, Quanjun Lu
    BMC Public Health.2018;[Epub]     CrossRef
  • 10,110 View
  • 281 Download
  • 17 Web of Science
  • 17 Crossref
Close layer
Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer
Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Myeong-Cherl Kook, Keun Won Ryu, Young-Woo Kim, Il Ju Choi
Cancer Res Treat. 2016;48(3):1020-1029.   Published online November 17, 2015
DOI: https://doi.org/10.4143/crt.2015.264
AbstractAbstract PDFPubReaderePub
Purpose
Negative Helicobacter pylori status has been identified as a poor prognostic factor for survival in gastric cancer (GC) patients who underwent surgery. The aim of this study was to examine the effect of H. pylori eradication on long-term outcomes after distal gastrectomy for GC.
Materials and Methods
We analyzed the survival of 169 distal GC patients enrolled in a prospective randomized trial evaluating histologic changes of gastric mucosa after H. pylori eradication in the remnant stomach. The outcomes measured were overall survival (OS) and GC recurrence rates.
Results
The median follow-up duration was 9.4 years. In the modified intention-to-treat analysis including patients who underwent H. pylori treatment (n=87) or placebo (n=82), 5-year OS rates were 98.9% in the treatment group and 91.5% in the placebo group, and KaplanMeier analysis showed no significant difference in OS (p=0.957) between groups. In multivariate analysis, no difference in overall mortality was observed between groups (adjusted hazard ratio [aHR] for H. pylori treatment, 0.75; p=0.495) or H. pylori-eradicated status (aHR for positive H. pylori status, 1.16; p=0.715), while old age, male sex, and advanced stage ≥ IIIa were independent risk factors. Six patients in the treatment group (6.9%) and seven patients in the placebo group (8.5%) had GC recurrences, and GC recurrence rates were not different according to H. pylori treatment (5-year GC recurrence rates, 4.6% in the treatment group vs. 8.5% in the placebo group; p=0.652).
Conclusion
H. pylori eradication for GC patients who underwent distal gastrectomy did not compromise long-term survival after surgery.

Citations

Citations to this article as recorded by  
  • Relationship between Helicobacter pylori infection and programmed death-ligand 1 in gastric cancer: A meta-analysis
    Hong-Chang Yang, Cheng-Feng Fu, Li-Jun Qiao, Gen-He Long, Li-Fen Yang, Biao Yao
    World Journal of Clinical Oncology.2025;[Epub]     CrossRef
  • The relationship between the eradication of Helicobacter pylori and the occurrence of stomach cancer: an updated meta-analysis and systemic review
    Zhouhan Wu, Yi Tang, Meiwen Tang, Zhoutong Wu, Yonghui Xu
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Anti–Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy
    Zhoukai Zhao, Ruopeng Zhang, Guoming Chen, Man Nie, Feiyang Zhang, Xiaojiang Chen, Jun Lin, Zewei Chen, Feizhi Lin, Chengzhi Wei, Ziqi Zheng, Shenghang Ruan, Bowen Huang, Yingbo Chen, Runcong Nie
    JAMA Network Open.2024; 7(3): e243812.     CrossRef
  • Helicobacter Pylori and Celiac Disease Antibody Positivity Have a Higher Prevalence in Patients With Distal Gastrectomy: A Cross-Sectional Retrospective Study
    Kubilay Issever, Ersin Kuloglu, Demet Sengul, Ali Muhtaroglu, Ahmet Cumhur Dulger
    Cureus.2023;[Epub]     CrossRef
  • The influence of partial gastrectomy for gastric cancer on the spontaneous disappearance of Helicobacter pylori: A single‐center prospective study
    Senichiro Yanagawa, Nobuaki Fujikuni, Kazuaki Tanabe, Masahiro Nakahara, Toshio Noriyuki
    Cancer Reports.2023;[Epub]     CrossRef
  • Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis
    Zhifang Jia, Min Zheng, Jing Jiang, Donghui Cao, Yanhua Wu, Yuzheng Zhang, Yingli Fu, Xueyuan Cao
    BMC Cancer.2022;[Epub]     CrossRef
  • Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, Kyu-Won Jung, Kui Son Choi
    Journal of Gastroenterology.2022; 57(7): 464.     CrossRef
  • Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
    Young-Il Kim, Il Ju Choi
    Journal of Gastric Cancer.2022; 22(3): 169.     CrossRef
  • Helicobacter Pylori and Gastric Cancer Progression
    Marina A. Senchukova
    Current Microbiology.2022;[Epub]     CrossRef
  • Identifying Factors Affecting Cancer-related Death in Patients with Adenocarcinoma Gastric Cancer; An Analysis in the Presence of Competing Risks
    Malihe Safari, Hossein Mahjub, Habib Esmaeili, Mohamad Abasi, Ghodratollah Roshanaei
    International Journal of Cancer Management.2021;[Epub]     CrossRef
  • T stage and venous invasion are crucial prognostic factors for long-term survival of patients with remnant gastric cancer: a cohort study
    Kentaro Matsuo, Sang-Woong Lee, Ryo Tanaka, Yoshiro Imai, Kotaro Honda, Kohei Taniguchi, Hideki Tomiyama, Kazuhisa Uchiyama
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Tracking the Virulent Helicobacter pylori Strains Instead of Its Pan-Screening to Prevent Gastric Cancer
    Farid Rahimi, Amin Talebi Bezmin Abadi
    BioNanoScience.2020; 10(1): 315.     CrossRef
  • Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis
    Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang
    Microbial Pathogenesis.2020; 142: 104075.     CrossRef
  • Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years
    Yonghoon Choi, Nayoung Kim, Chang Yong Yun, Yoon Jin Choi, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Sang-Hoon Ahn, Do Joong Park, Hye Seung Lee, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim
    Gastric Cancer.2020; 23(6): 1051.     CrossRef
  • Impact of the timing of Helicobacter pylori eradication on the risk of development of metachronous lesions after treatment of early gastric cancer: a population-based cohort study
    Hyun Ju Kim, Yun Jin Kim, Seung In Seo, Woon Geon Shin, Chan Hyuk Park
    Gastrointestinal Endoscopy.2020; 92(3): 613.     CrossRef
  • Helicobacter pylori Eradication in Patients Undergoing Gastrectomy: Diagnosis and Therapy
    Youn I Choi, Jun-Won Chung
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2020; 20(3): 204.     CrossRef
  • Helicobacter pylori Eradication in Adult Patients with Acute Idiopathic Thrombocytopenic Purpura (ITP)
    Minoosh Moghimi, Yousef Mortazavi, Saeed Razavi-Dizaji, Shahrbanoo Keyhanian, Zahra Ghadimi, Sahar Baba Ali, Saeideh Mazloomzadeh, Sattar Jafari, Reza Mansouri, Masoud Asadi-Khiavi
    Journal of Advances in Medical and Biomedical Research.2019; 27(124): 1.     CrossRef
  • Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
    Il Ju Choi, Myeong-Cherl Kook, Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Byung-Ho Nam
    New England Journal of Medicine.2018; 378(12): 1085.     CrossRef
  • Helicobacter pyloriEradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
    Bum Jun Kim, Hyeong Su Kim, Hyun Joo Jang, Jung Han Kim
    Gastroenterology Research and Practice.2018; 2018: 1.     CrossRef
  • Do We Need to Retest of Helicobacter pylori Infection after Gastric Cancer Surgery?
    Sang Kil Lee
    Gut and Liver.2017; 11(2): 169.     CrossRef
  • 12,489 View
  • 203 Download
  • 19 Web of Science
  • 20 Crossref
Close layer
Long-Term Low-Dose Aspirin Use Reduces Gastric Cancer Incidence: A Nationwide Cohort Study
Young-Il Kim, So Young Kim, Ji Hyun Kim, Jun Ho Lee, Young-Woo Kim, Keun Won Ryu, Jong-Hyock Park, Il Ju Choi
Cancer Res Treat. 2016;48(2):798-805.   Published online July 14, 2015
DOI: https://doi.org/10.4143/crt.2015.117
AbstractAbstract PDFPubReaderePub
Purpose
The aim of this study was to investigate whether aspirin use can reduce the incidence of gastric cancer in patients with hypertension or type 2 diabetes. Materials and Methods A total of 200,000 patients with hypertension or type 2 diabetes were randomly selected from the Korean National Health Insurance claim database. Of these, 3,907 patients who used 100 mg of aspirin regularly (regular aspirin users) and 7,808 patients who did not use aspirin regularly (aspirin non-users) were selected at a frequency of 1:2, matched by age, sex, comorbid illnesses (type 2 diabetes and hypertension), and observation periods. The incidence of gastric cancer in this cohort was then assessed during the observation period of 2004 to 2010.
Results
In the matched cohort, the incidence rates of gastric cancer were 0.8% (31/3,907) for regular aspirin users and 1.1% (86/7,808) for aspirin non-users, but the cumulative incidence rates were not significantly different between groups (p=0.116, log-rank test). However, in multivariate analysis, regular aspirin users had a reduced risk of gastric cancer (adjusted hazard ratio [aHR], 0.71; 95% confidential interval [CI], 0.47 to 1.08; p=0.107). Duration of aspirin use showed significant association with reduction of gastric cancer risk (aHR for each year of aspirin use, 0.85; 95% CI, 0.73 to 0.99; p=0.044), particularly in patients who used aspirin for more than 3 years (aHR, 0.40; 95% CI, 0.16 to 0.98; p=0.045). Conclusion Long-term low-dose aspirin use was associated with reduced gastric cancer risk in patients with hypertension or type 2 diabetes.

Citations

Citations to this article as recorded by  
  • Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses
    Xiao Bai, Si-Qi Ding, Xue-Ping Zhang, Ming-Hao Han, Dong-Qiu Dai
    Cancers.2023; 15(2): 372.     CrossRef
  • In Vitro Assessment of the Synergistic Effect of Aspirin and 5-Fluorouracil in Colorectal Adenocarcinoma Cells
    Monica Susan, Ioana Macasoi, Iulia Pinzaru, Cristina Dehelean, Iosif Ilia, Razvan Susan, Ioana Ionita
    Current Oncology.2023; 30(7): 6197.     CrossRef
  • Prediction algorithm for gastric cancer in a general population: A validation study
    Martin C. S. Wong, Eman Yee‐man Leung, Sarah T. Y. Yau, Sze Chai Chan, Shaohua Xie, Wanghong Xu, Junjie Huang
    Cancer Medicine.2023; 12(21): 20544.     CrossRef
  • Evaluation of clopidogrel use on gastric precancerous lesions: Does it have chemopreventive effect?
    Taner AKYOL
    Journal of Medicine and Palliative Care.2023; 4(5): 524.     CrossRef
  • Safety and effectiveness of low-dose aspirin for the prevention of gastrointestinal cancer in adults without atherosclerotic cardiovascular disease: a population-based cohort study
    Jessica J P Shami, Jiaxi Zhao, Swathi Pathadka, Eric Yuk Fai Wan, Joseph Edgar Blais, Pareen Vora, Montse Soriano-Gabarró, Ka Shing Cheung, W K Leung, Ian C K Wong, Esther W Chan
    BMJ Open.2022; 12(2): e050510.     CrossRef
  • Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study
    Sohee Kwon, Wenjie Ma, David A. Drew, Samuel J. Klempner, Brianna M. Leonardo, Jacqueline J. Flynn, Yin Cao, Edward L. Giovannucci, Ying Bao, Charles S. Fuchs, Mingyang Song, Andrew T. Chan
    Cancer Prevention Research.2022; 15(4): 265.     CrossRef
  • Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study
    Mi Hee Cho, Tae Gon Yoo, Su-Min Jeong, Dong Wook Shin
    Cancer Prevention Research.2021; 14(1): 95.     CrossRef
  • Antibreast Cancer Activity of Aspirin-Conjugated Chalcone Polymeric Micelles
    Do Young Lee, Kang Pa Lee, Suji Beak, Ji Su Park, Young Jin Kim, Kil-Nam Kim, Song-Rae Kim, Myeong Sik Yoon
    Macromolecular Research.2021; 29(1): 105.     CrossRef
  • Effect of frequently prescribed drugs on gastric cancer risk
    Theresa Weltermann, Christian Schulz, Lukas Macke
    Best Practice & Research Clinical Gastroenterology.2021; : 101741.     CrossRef
  • Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials
    Lijuan Wang, Rongqi Zhang, Lili Yu, Jiarui Xiao, Xuan Zhou, Xinxuan Li, Peige Song, Xue Li
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature
    Chin-Hsiao Tseng
    Biomolecules.2021; 11(7): 1022.     CrossRef
  • Effect of aspirin use on gastric cancer incidence and survival: A systematic review and meta‐analysis
    Ryota Niikura, Yoshihiro Hirata, Yoku Hayakawa, Takuya Kawahara, Atsuo Yamada, Kazuhiko Koike
    JGH Open.2020; 4(2): 117.     CrossRef
  • Positive association between dietary inflammatory index and gastric cancer risk: A systematic review and meta-analysis
    Ying Liang, Haoyan Jiao, Lingbo Qu, Hao Liu
    Nutrition and Cancer.2020; 72(8): 1290.     CrossRef
  • Efficacy of Aspirin in the Primary Prevention of Cardiovascular Diseases and Cancer in the Elderly: A Population-Based Cohort Study in Korea
    Minji Jung, Sukhyang Lee
    Drugs & Aging.2020; 37(1): 43.     CrossRef
  • Safety of Proton Pump Inhibitors Questioned Based on a Large Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
    Johanna Simin, Qing Liu, Romina Fornes, Nele Brusselaers
    Gastroenterology.2020; 158(4): 1172.     CrossRef
  • De novo malignancy risk in patients undergoing the first percutaneous coronary intervention: A nationwide population-based cohort study
    Soongu Kwak, You-Jung Choi, Soonil Kwon, Seo-Young Lee, Seokhun Yang, Inki Moon, Hyun-Jung Lee, Heesun Lee, Jun-Bean Park, Kyungdo Han, Yong-Jin Kim, Hyung-Kwan Kim
    International Journal of Cardiology.2020; 313: 25.     CrossRef
  • Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies
    Peipei Liu, Úna C. McMenamin, Brian T. Johnston, Peter Murchie, Lisa Iversen, Amanda J. Lee, Pauline A. J. Vissers, Chris R. Cardwell
    British Journal of Cancer.2020; 123(2): 307.     CrossRef
  • Low‐dose aspirin and risk of gastric and oesophageal cancer: A population‐based study in the United Kingdom using The Health Improvement Network
    Luis A. García Rodríguez, Montse Soriano‐Gabarró, Pareen Vora, Lucía Cea Soriano
    International Journal of Cancer.2020; 147(9): 2394.     CrossRef
  • Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin
    Jiro Watari, Toshihiko Tomita, Katsuyuki Tozawa, Tadayuki Oshima, Hirokazu Fukui, Hiroto Miwa
    Gut and Liver.2020; 14(3): 281.     CrossRef
  • Acetylsalicylic Acid Exerts Potent Antitumor and Antiangiogenic Effects in Cutaneous and Uveal Melanoma Cell Lines
    Dominique Fausto de Souza, Thupten Tsering, Miguel N. Burnier , Vasco Bravo-Filho, Ana Beatriz Toledo Dias, Mohamed Abdouh, Alicia Goyeneche, Julia Valdemarin Burnier
    Ocular Oncology and Pathology.2020; 6(6): 442.     CrossRef
  • Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
    Yan Qiao, Tingting Yang, Yong Gan, Wenzhen Li, Chao Wang, Yanhong Gong, Zuxun Lu
    BMC Cancer.2018;[Epub]     CrossRef
  • Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer
    Min-hyung Kim, Jooyoung Chang, Warrick Junsuk Kim, Samprit Banerjee, Sang Min Park
    American Journal of Gastroenterology.2018; 113(6): 845.     CrossRef
  • Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis
    Yu-Shan Lin, Chih-Ching Yeh, Shiang-Fu Huang, Yi-Sheng Chou, Li-Tang Kuo, Fung-Chang Sung, Chih-Hsin Muo, Chien-Tien Su, Fu-Hsiung Su, Mohammad R. Akbari
    PLOS ONE.2018; 13(8): e0199014.     CrossRef
  • Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer
    Min-hyung Kim, Jooyoung Chang, Warrick Junsuk Kim, Samprit Banerjee, Sang Min Park
    American Journal of Gastroenterology.2018; 113(6): 845.     CrossRef
  • Chemoprevention of Gastric Cancer: Non-steroidal Anti-inflammatory Drugs Including Aspirin
    Kee Don Choi
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(4): 169.     CrossRef
  • Effects of long-term aspirin use on molecular alterations in precancerous gastric mucosa in patients with and without gastric cancer
    Yuki Michigami, Jiro Watari, Chiyomi Ito, Ken Hara, Takahisa Yamasaki, Takashi Kondo, Tomoaki Kono, Katsuyuki Tozawa, Toshihiko Tomita, Tadayuki Oshima, Hirokazu Fukui, Takeshi Morimoto, Kiron M. Das, Hiroto Miwa
    Scientific Reports.2017;[Epub]     CrossRef
  • Aspirin enhances the cytotoxic activity of bortezomib against myeloma cells via suppression of Bcl-2, survivin and phosphorylation of AKT
    Jiang-Hua Ding, Li-Ya Yuan, Guo-An Chen
    Oncology Letters.2017; 13(2): 647.     CrossRef
  • Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis
    Xuan-zhang Huang, You Chen, Jian Wu, Xi Zhang, Cong-cong Wu, Chao-ying Zhang, Shuang-shuang Sun, Wen-jun Chen
    Oncotarget.2017; 8(3): 4781.     CrossRef
  • Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer
    Jing Zhang, Shu-Qi Li, Zhi-Hua Liao, Yu-Huan Jiang, Qing-Gen Chen, Bo Huang, Jing Liu, Yan-Mei Xu, Jin Lin, Hou-Qun Ying, Xiao-Zhong Wang
    Oncotarget.2017; 8(43): 75195.     CrossRef
  • Dietary inflammatory index and the risk of gastric cancer in a Korean population
    Sunghee Lee, Jeonghee Lee, Il Ju Choi, Young-Woo Kim, Keun Won Ryu, Young-Il Kim, Jin-Kyoung Oh, Binh Thang Tran, Jeongseon Kim
    Oncotarget.2017; 8(49): 85452.     CrossRef
  • 13,313 View
  • 183 Download
  • 35 Web of Science
  • 30 Crossref
Close layer
Effects of Polymorphisms of Innate Immunity Genes and Environmental Factors on the Risk of Noncardia Gastric Cancer
Jeongseon Kim, Young Ae Cho, Il Ju Choi, Yeon-Su Lee, Sook-Young Kim, Jung-Ah Hwang, Soo-Jeong Cho, Myeong-Cherl Kook, Chan Gyoo Kim, Young-Woo Kim
Cancer Res Treat. 2013;45(4):313-324.   Published online December 31, 2013
DOI: https://doi.org/10.4143/crt.2013.45.4.313
AbstractAbstract PDFPubReaderePub
PURPOSE
Increasing evidence suggests that polymorphisms in innate immunity genes are associated with Helicobacter pylori-induced inflammation and may influence susceptibility in developing noncardia gastric cancer. Therefore, we investigate the effect of polymorphisms of innate immunity genes and interactions with environmental factors in the Korean population.
MATERIALS AND METHODS
We genotyped four polymorphisms of TLR2 (rs1898830), TLR4 (rs10983755 and rs10759932), and CD14 (rs2569190) in a case-control study of 487 noncardia gastric cancer patients and 487 sex- and age-matched healthy controls. Polytomous logistic regression models were used to detect the effects of genetic polymorphisms and environmental factors, which were stratified by the histological type of gastric cancer.
RESULTS
TLR4 rs10983755 A carriers were found to have higher risk of intestinal-type noncarida gastric cancer than G homozygotes (odds ratio [OR], 1.41; 95% confidence interval [CI], 1.01 to 1.97), but other genetic variants showed no association with the risk of noncardia gastric cancer. Among H. pylori-positive participants, smokers carrying TLR4 rs10983755 A had a higher risk of intestinal-type gastric cancer than nonsmoking TLR4 rs10983755 G homozygotes (OR, 4.28; 95% CI, 2.12 to 8.64). In addition, compared with tap water, other drinking water sources during childhood were found to be associated with the elevated risk of intestinal-type gastric cancer, and these associations were slightly stronger among TLR4 rs10983755 A carriers.
CONCLUSION
The genetic polymorphisms of innate immunity genes are associated with the development of intestinal-type noncardia gastric cancer and these associations may differ in accordance to an exposure to certain environmental factors.

Citations

Citations to this article as recorded by  
  • Association between Toll-like receptor 2 rs4696483 and rs1898830 polymorphisms and the risk of triple-negative breast cancer
    Rabeb M. Ghali, Sonia Zaied, Amira Daldoul, Perizat Kanabekova, Wassim Y. Almawi
    Gene.2024; 928: 148773.     CrossRef
  • Pathomorphological Manifestations and the Course of the Cervical Cancer Disease Determined by Variations in the TLR4 Gene
    Eglė Žilienė, Arturas Inčiūra, Rasa Ugenskienė, Elona Juozaitytė
    Diagnostics.2023; 13(12): 1999.     CrossRef
  • Ranking and Prioritizing Risk Factors for Gastric Cancer
    Ali Reza Yusefi, Shima Bordbar, Gholamhossein Mehralian, Kamran Bagheri Lankarani, Mohammad Khammarnia, Zahra Kavosi, Peivand Bastani
    The Open Public Health Journal.2023;[Epub]     CrossRef
  • Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis
    Ayoub Al Othaim, Sulieman Ibraheem Shelash Al-Hawary, Hashem O. Alsaab, Sami G. Almalki, Mazin A. A. Najm, Ahmed Hjazi, Ali Alsalamy, Abbas Firras Almulla, Hamzeh Alizadeh
    Frontiers in Genetics.2023;[Epub]     CrossRef
  • Association between EPHA5 methylation status in peripheral blood leukocytes and the risk and prognosis of gastric cancer
    Xu Han, Tianyu Liu, Jiabao Zhai, Chang Liu, Wanyu Wang, Chuang Nie, Qi Wang, Xiaojie Zhu, Haibo Zhou, Wenjing Tian
    PeerJ.2022; 10: e13774.     CrossRef
  • Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate
    Debashis Dutta, Moumita Majumder, Ramesh Kumar Paidi, Kalipada Pahan
    Neurobiology of Disease.2021; 153: 105318.     CrossRef
  • Demethylation of the RB1 promoter concomitant with reactivation of TET2 and TET3 impairs gastric carcinogenesis in K19-Wnt1/C2mE transgenic mice
    Donghui Cao, Zhifang Jia, Yanhua Wu, Tongrong Su, Dan Zhao, Menghui Wu, Tetsuya Tsukamoto, Masanobu Oshima, Jing Jiang, Xueyuan Cao
    Life Sciences.2020; 263: 118580.     CrossRef
  • Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract
    Evagelia Spanou, Polyxeni Kalisperati, Ioannis S. Pateras, Alexandros Papalampros, Alexandra Barbouti, Athanasios G. Tzioufas, Athanassios Kotsinas, Stavros Sougioultzis
    Frontiers in Genetics.2017;[Epub]     CrossRef
  • Increased deaths from gastric cancer in communities living close to waste landfills
    Agostino Di Ciaula
    International Journal of Environmental Health Research.2016; 26(3): 281.     CrossRef
  • Correlation of Serum Levels of Endostatin with Tumor Stage in Gastric Cancer: A Systematic Review and Meta-Analysis
    Zheng-Hua Wang, Zhi-Tu Zhu, Xu-Yang Xiao, Jin Sun
    BioMed Research International.2015; 2015: 1.     CrossRef
  • Pattern-Recognition Receptors and Gastric Cancer
    Natalia Castaño-Rodríguez, Nadeem O. Kaakoush, Hazel M. Mitchell
    Frontiers in Immunology.2014;[Epub]     CrossRef
  • 12,664 View
  • 63 Download
  • 11 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP